Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
1(50.0%)
Phase 3
1(50.0%)
2Total
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06358872Phase 4Recruiting

Azithromycin for Child Survival in Niger II

Role: collaborator

NCT05886179Completed

COVID-19 IN CHILDREN IN NIGER, 2020

Role: lead

NCT04409483Phase 3Withdrawn

Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger

Role: collaborator

All 3 trials loaded